@article{Cortese_S-2020_6654,
title = {Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group},
author = {Cortese, S. and Coghill, D. and Santosh, P. and Hollis, C. and Simonoff, E.},
month = {jun},
year = {2020},
abstract = {This addendum to our previous comment provides additional guidance from the European ADHD Guidelines Group (EAGG) on starting attention-deficit hyperactivity disorder (ADHD) medications (specifically psychostimulants and atomoxetine), during the coronavirus disease 2019 (COVID-19) pandemic, for patients who did not have a baseline, face-toface cardiovascular assessment before the crisis began.},
pages = {E15-E15},
volume = {4},
issue = {6},
journal = {The Lancet Child & Adolescent Health },
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2352-4642(20)30144-9},
}
